Cargando…
Emerging Pharmacotherapeutic Strategies to Overcome Undruggable Proteins in Cancer
Targeted therapies in cancer treatment can improve in vivo efficacy and reduce adverse effects by altering the tissue exposure of specific biomolecules. However, there are still large number of target proteins in cancer are still undruggable, owing to the following factors including (1) lack of liga...
Autores principales: | Lu, Yuqing, Yang, Yuewen, Zhu, Guanghao, Zeng, Hairong, Fan, Yiming, Guo, Fujia, Xu, Dongshu, Wang, Boya, Chen, Dapeng, Ge, Guangbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367563/ https://www.ncbi.nlm.nih.gov/pubmed/37496997 http://dx.doi.org/10.7150/ijbs.83026 |
Ejemplares similares
-
Chemically Induced Cellular Proteolysis: An Emerging Therapeutic Strategy for Undruggable Targets
por: Moon, Seonghyeon, et al.
Publicado: (2018) -
Targeting the “undruggable” RAS - new strategies - new hope?
por: Mörchen, Britta, et al.
Publicado: (2019) -
Drugging an undruggable pocket on KRAS
por: Kessler, Dirk, et al.
Publicado: (2019) -
Therapeutic targeting of “undruggable” MYC
por: Llombart, Victor, et al.
Publicado: (2021) -
KRAS mutation: from undruggable to druggable in cancer
por: Huang, Lamei, et al.
Publicado: (2021)